ADC analysis

Be clear on what you have and how much.

Understand ADC drug loading profiles regardless of the inherent heterogeneity and high molecular weight of these molecules. 

Request info

Overview

Up the game for ADC analysis

ADC analysis strategies tackle the characterization of the more structurally complex antibody drug conjugates (ADC) that are providing the next level of therapeutics to combat specific conditions.
These molecules have greater heterogeneity compared to unconjugated proteins and have a variable number of linkers and payloads. This enhances the number of proteoforms, making characterization more challenging.

Take control of the information with MS and CE based solutions designed to address the complexity of these next generation therapeutics with increased speed and detail.

Workflow

Intact ADC characterization

Untangle the charge heterogeneity information of an intact ADC.

Charge heterogeneity is present in most biopharmaceutical protein products. For ADCs, the antibody, linker and payload all contribute to the heterogeneity, adding complexity to the charge variant profiles. 

An integrated icIEF-UV/MS workflow enables the simple determination of charge variant profiles while reducing resources and accelerating development timelines. Determine what is driving the change in the charge profile–the payload, the linker or the monoclonal antibody (mAb).  

  • Reduce charge heterogeneity analysis workflow from weeks to minutes
  • Elucidate critical post-translational modifications (PTMs) including glycosylation, deamidation and linker modifications
  • Enable mass identification of charge variants and modifications on intact ADCs
  • Monitor charged modifications on ADC payload in near real-time

Intact ADC chacterization

Solution

Suited for:
  • Intact protein analysis of ADC molecules
  • Real-time monitoring of ADC payload modifications
  • In-depth characterization of PTMs on the ADC mAb
Request info
Request info

Workflow

Drug antibody ratio monitoring

Take control of information on ADC quality. Drug antibody ratio (DAR) information is essential for assessing the quality of ADCs. Be clear on what you have. Understand ADC drug loading profiles with high throughput and intuitive LC/MS and CE solutions for DAR monitoring at the intact protein level.

  • Complete solution for acquisition and tracking of DAR changes
  • High-throughput DAR monitoring for large sample sets
  • DAR quantitation and monitoring on compliance-ready software

Drug antibody ratio monitoring

Solutions

Suited for:
  • Routine monitoring of DAR for ADCs
  • Comprehensive assessment of DAR
Request info
Request info

Suited for:
  • Routine monitoring of DAR for ADCs
  • Comprehensive assessment of DAR
Request info
Request info

Suited for:
  • Routine monitoring of DAR for ADCs
  • Targeted assessment of DAR
Request info
Request info

Suited for:
  • Calculating DAR ratios with CE
Request info
Request info

Workflow

Characterization of ADC raw material

Build on a strong backbone.
ADCs are complex molecules consisting of an antibody chemically tethered to a drug payload. While the complexity of the association is important to understand, the raw material itself is also fundamental to the success of the method of action and requires characterization. Accelerate ADC analysis with characterization of raw materials using high-throughput CE-based workflows.

  • High-throughput assays for purity, charge heterogeneity and N-linked glycans
  • Reduce method development time with parallel processing

Characterization of ADC raw material

Solution

Suited for:
  • High-throughput purity analysis
  • Rapid CE-SDS assay
Request info
Request info

Characterization of ADC raw material

Solution

Suited for:
  • High-throughput charge heterogeneity analysis
  • Rapid cIEF assay
Request info
Request info

Characterization of ADC raw material

Solution

Suited for:
  • High-throughput N-linked glycan analysis
  • Rapid glycan expression profiling
Request info
Request info

All resources

Filter:
Automate DAR calculation at the intact level.

Ensure product quality and make ADC analysis accessible with a visually intuitive workflow for routine ADC characterization.

Enable comprehensive analysis of mAbs and ADCs in a single injection

Gain accurate localization and detailed structural characterization with improved sensitivity for confident detection of fragments

Enable mass identification of charge variants and modifications on intact ADCs

Reduce charge heterogeneity analysis from weeks to minutes. Identify and monitor the charged modifications on ADC payloads in near real-time.

Comprehensive characterization of protein therapeutics

Gain high sequence coverage for proteins and identify critical modifications on a single platform solution

Enable faster decision making with high-throughput and intuitive DAR monitoring for ADCs

Streamlined LC-MS based workflows, with user-friendly data analysis software to enable attribute monitoring and informed decision making during process development.

Eliminate the bottleneck for drug purity analysis with high-throughput rapid CE-SDS purity analysis

Screen a large number of clones for lead clone selection with automation friendly mulit-capillary CE-SDS workflow.

Accelerate cIEF method development from days to hours

Streamline evalutaion of multiple factors in a single set of experiments with a multifactorial DoE approach.

Enable a streamlined, accurate and high-throughput glycan analysis assay

High throughput glycan expression profiling with automation friendly sample preparation and labeling.

Associated applications

Intact protein analysis

Confidently select lead candidates and ensure reproducible product quality. Discover fast and reliable solutions that simplify identification and characterization of complex molecules at the intact level.

Learn more
Subunit mass analysis and middle-down

Take control of the unknowns. Gain confident sequence confirmation and localization of post-translational modifications (PTMs) at the sub-unit level.

Learn more
Peptide analysis

Achieve new heights in PTM analysis with confidence and speed. Define critical quality attributes (CQAs) and streamline processes from early to late-stage development with in-depth peptide mapping solutions for next-generation protein therapeutics and standard monoclonal antibodies (mAbs).

Learn more
Contact SCIEX
Don't see a solution that works for you? Request more information to understand how our products can fit your needs.